The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial.
Takashi NomuraEriko SumiGyohei EgawaSaeko NakajimaEiko ToichiRyuji UozumiHarue TadaTakayuki NakagawaMasatoshi HagiwaraKenji KabashimaPublished in: Trials (2019)
UMIN Clinical Trials, UMIN000029695 . Registered on 1 November 2017.